Skip to main
Clinic Semaglutide

A generative reading of the semaglutide evidence base — GLP-1 receptor pharmacology, the STEP and SELECT trials, and what the literature actually measured.

Semaglutide for Weight Loss: Results in People

What semaglutide for weight loss changed in stage 3 studies

What did semaglutide for weight loss change? STEP studies found weight stayed down in several groups. STEP 1 through STEP 8 included adults with obesity. Some had diabetes or heart disease. STEP TEENS included teens. STEP UP tested a larger dose. In STEP 1, average loss was 14.9% at 68 weeks.

SELECT asked whether heart harm changed too. Adults with obesity had 20% less major heart harm [2]. None had diabetes. The 208-week check found average weight was still down ~10% [14]. That's about four years. Your change may differ from the group average.

What weight changes Semaglutide studies measured

In 2021, STEP 1 followed 1,961 adults for 68 weeks. None had diabetes. Average loss was 14.9% on semaglutide and 2.4% on a placebo. At least 5% came off for 86.4%. Loss reached ≥10% for 69.1% and ≥15% for 50.5%. Waists fell −13.5 cm versus −4.1 cm [1].

How long did 30 pounds take? STEP 1 gives only the group average at 68 weeks. At 220 lbs, or about 100 kg, 14.9% is about 32.8 lbs. So 30-lb loss fell near that average. It wasn't promised for each person. Start weight, food, dose, and missed shots all mattered [1].

The 208-week results kept average loss near 10%. A lower BMI group was reached by 52.4%. Normal BMI was reached by 12% on semaglutide. A placebo reached 1.2% [14].

In 2025, STEP UP followed 803 people. The 7.2 mg group lost −18.7% on average. The 2.4 mg group lost −15.6% [17]. More drug brought more weight loss in that study.

What weight changes Semaglutide studies measured

What Semaglutide changed in deep belly fat

Will semaglutide reduce deep belly fat? MRI scans in STEP found more loss around the organs. STEP 1 found waists fell −13.5 cm [1]. At 208 weeks, SELECT found −7.7 cm on semaglutide. A placebo brought −1.3 cm [14]. Smaller waists went with better signs of heart health.

Deep belly fat is tied to heart and liver harm. It is also tied to insulin not working well. The MRI scans suggest more of this fat came off [14]. They don't show why. Tests in cells found changes in how fat burns fuel [18]. That lab work may help explain the scans. It doesn't prove the cause in people.

What Semaglutide does to hunger and meals

Semaglutide acts like GLP-1 in a brain area that helps set hunger. It makes hunger-curbing cells more active. It quiets cells that drive hunger [11]. Food also stays in the stomach longer. Together, these GLP-1 changes cut how much people ate by about 24% in studies.

The drug has a 168-hour half-life. Its effect on hunger can last all week. It doesn't rise and fade after each meal. In mice, the brain change peaked 12–24 hours after a shot [11]. That's work in mice, not proof of timing in people.

The semaglutide mechanism of action page explains more. The semaglutide dosing schedule compares dose levels. The plain result: less hunger led to less food.

What Semaglutide may change about alcohol use

In 2025, a stage 2 study followed 48 adults for 9 weeks. People had fewer heavy drinking days on semaglutide. They drank less each time and felt less craving [9]. The change was large enough to stand out. Rats and mice also drank less as doses rose. Brain tests in those animals found changes in two areas tied to reward [10].

The study in people was small and short. Work in rats and mice can't prove a human result. Both studies suggest the GLP-1 drug may affect reward, not just hunger. As of 2025, the alcohol work was still at stage 2. It still needed a large stage 3 test. This isn't a settled treatment.